ArticleInvestigational new drugs2014

Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes.

Julie C Friedland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.